Insights into the trimeric HIV-1 envelope glycoprotein structure
about
HIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchDynamic Viral Glycoprotein Machines: Approaches for Probing Transient States That Drive Membrane FusionThe HIV glycan shield as a target for broadly neutralizing antibodiesAntibody responses to envelope glycoproteins in HIV-1 infectionProtein Crystallography in Vaccine Research and DevelopmentCell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 EnvelopeCross-Neutralizing Antibodies in HIV-1 Individuals Infected by Subtypes B, F1, C or the B/Bbr Variant in Relation to the Genetics and Biochemical Characteristics of the env GeneFunctional organization of the HIV lipid envelopeLessons learned from human HIV vaccine trials.Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune SystemCoexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controllerA New Approach to Produce HIV-1 Envelope Trimers: BOTH CLEAVAGE AND PROPER GLYCOSYLATION ARE ESSENTIAL TO GENERATE AUTHENTIC TRIMERSMorphology and ultrastructure of retrovirus particles.Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C.Native Conformation and Canonical Disulfide Bond Formation Are Interlinked Properties of HIV-1 Env Glycoproteins.Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency.Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif.Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.Natural infection as a blueprint for rational HIV vaccine design.Structure and Glycan Binding of a New Cyanovirin-N Homolog.New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design.Genetic and structural analyses of affinity maturation in the humoral response to HIV-1.Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development.The HIV-1 envelope glycoprotein structure: nailing down a moving target.Role of germinal centers for the induction of broadly-reactive memory B cells.Selection of nanobodies with broad neutralizing potential against primary HIV-1 strains using soluble subtype C gp140 envelope trimers.Mammalian cell surface display for monoclonal antibody-based FACS selection of viral envelope proteins.Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop.The Tetrameric Plant Lectin BanLec Neutralizes HIV through Bidentate Binding to Specific Viral Glycans.What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise.Determinants of HIV-1 broadly neutralizing antibody induction.Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design.Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans.Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers.Targeted Elimination of Immunodominant B Cells Drives the Germinal Center Reaction toward Subdominant Epitopes.Six-helix bundle completion in the distal C-terminal heptad repeat region of gp41 is required for efficient human immunodeficiency virus type 1 infection.Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation.
P2860
Q26746070-1E496217-CDD7-4B4C-932A-2292E1A304E1Q26772129-613AD937-A551-4A44-94B0-54CB09F61B77Q26786540-AFC7EC62-2D26-41E7-AF57-31346EC6A408Q26991572-DB3C438C-A345-4753-8A2D-0D3559816D1EQ28087528-71A82480-E7DE-4A4A-8976-FDD8240AEF82Q28263655-640F368D-2F01-4853-AB79-717CC1C11403Q28554907-BD96FD27-075D-4ADC-8A25-9F2F616509F0Q28828700-1F8DED17-9BC4-469F-9860-FDA7E079EBA9Q33557844-2DD90695-B47E-4138-9C95-445E1B558431Q33592852-3AA7FCB1-731D-45C2-8A79-890D65D09583Q33786447-D71E4B97-C7C4-4AF2-B41B-18F63B557A77Q35925858-DC685581-54FD-49A8-926D-45EFBE03D69BQ36121053-1CFCF92C-4FC6-492A-8EB7-5EABFCA78C5BQ36132706-90576726-3FE9-4B7F-ACE8-AB6445BA4BD0Q36736597-FFF5B9D3-45B0-46F6-9863-AD5210DA5011Q36736610-ABBE6A00-92CC-413C-95FB-D58B11261504Q36811996-9ACBBC47-FE88-41D6-BC93-A9E3982970BDQ37145901-D591DD28-8461-49F6-B375-78BAFBCF683FQ37448281-727A178B-7F72-4D08-834F-0D244F611CA1Q37584635-B85D1F1A-B5A4-40AD-A0BB-6D92C10A6B26Q37593177-8F44F26F-D518-4C00-9FCC-6E2D326C27B1Q37619134-F669A9F8-F3C5-4E20-A72A-CC5841EEDFD3Q38291748-0B17CD71-DF0A-46D9-A1E1-73861AFEC596Q38748193-BE98BEFA-E968-4155-9D70-60EAD661C9D5Q38992744-DB142661-2333-4C5D-A8AF-459EE3CDEF3CQ39108751-30A32429-1CD3-4688-801B-DCAE6205E172Q39108789-FCC92D9D-9FF6-4AFA-B636-41156A9500A9Q39206970-B05B91B1-830B-44CE-AAE3-069C639985C9Q40076041-DF69B2A4-57EC-4771-B377-01388E809797Q40080000-831D9F28-FA11-4D6B-8742-546F61C162AAQ40198060-76A3FD07-A33B-4AAB-875B-81AA3A4427ACQ40231057-8C6F08A8-199F-4089-91B0-F1954DE82EC3Q40346058-0FE27B0A-80C2-4598-8A3C-73632A56D26CQ40476608-338BEDFF-1A43-4E87-A80F-FAC9A1201684Q40679052-25E69316-438D-4262-B904-58E8B9D26654Q41037927-5C39EFA8-3BE7-47F7-BA4F-7D4AA33F3E7BQ41447893-BD5E94AF-5ED8-4D78-A85B-41699207C74DQ47560170-94C9C1B5-026E-4B6F-9E5F-E3FC875023BAQ52334297-9A73CC74-E7A9-4649-8A45-E3395500C219Q53689028-5AE0FE97-DE41-410F-A38F-F526546D5031
P2860
Insights into the trimeric HIV-1 envelope glycoprotein structure
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Insights into the trimeric HIV-1 envelope glycoprotein structure
@en
type
label
Insights into the trimeric HIV-1 envelope glycoprotein structure
@en
prefLabel
Insights into the trimeric HIV-1 envelope glycoprotein structure
@en
P2860
P1476
Insights into the trimeric HIV-1 envelope glycoprotein structure
@en
P2093
Andrew B Ward
P2860
P304
P356
10.1016/J.TIBS.2014.12.006
P577
2015-01-16T00:00:00Z